Remdesivir Treatment for COVID 19 in Pregnant Patients with Moderate to Severe Symptoms: Serial Case Report.

Yudianto Budi SaroyoAmanda RumondangIrene Sinta FebrianaAchmad Kemal Harzif Rima Irwinda

Published in: Infectious disease reports (2021)

Remdesivir protocol for pregnant women with moderate to severe symptoms of COVID-19 has resulted in better clinical improvement with a shorter recovery period and no adverse effects during the hospitalization period. Further studies and RCT are warranted to evaluate the biosafety and effects of Remdesivir in pregnant women.

Keyphrases

pregnant women
coronavirus disease
sars cov
case report
high intensity
early onset
randomized controlled trial
sleep quality
pregnancy outcomes
physical activity
case control
depressive symptoms
replacement therapy